PHASE I PK STUDY OF BMS-247550 IN ADVANCED MALIGNANCIES AND LIVER DYSFUNCTION

BMS-247550 在晚期恶性肿瘤和肝功能障碍中的 I 期 PK 研究

• 批准号: 7607514
• 负责人: GEORGE WILDING
• 金额: $ 0.11万
• 依托单位: UNIVERSITY OF WISCONSIN-MADISON
• 依托单位国家: 美国
• 财政年份: 2006
• 资助国家: 美国
• 起止时间: 2006-12-01 至 2007-09-16
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/7607514
• 关键词: Clinical Trials; Computer Retrieval of Information on Scientific Projects Database; Databases; Drug usage; Effectiveness; Functional disorder; Funding; Grant; Hepatic Lymphoma; Hour; Infusion procedures; Institution; Liver Dysfunction; Malignant Neoplasms; National Cancer Institute; Patients; Phase; Phase I Clinical Trials; Physician Data Query; Recruitment Activity; Research; Research Personnel; Resources; Solid Neoplasm; Source; United States National Institutes of Health; Week; Work; chemotherapy; neoplastic cell

This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. This study is no longer recruiting subjects. (Clinical trial summary from the National Cancer Institute's PDQ¿ database) Drugs used in chemotherapy work in different ways to stop tumor cells from dividing so they stop growing or die. This is a Phase I trial to study the effectiveness of BMS-247550 in treating patients who have advanced solid tumors or lymphomas and liver dysfunction. Patients will receive a 3-hour infusion of BMS-247550 every 3 weeks. Treatment may continue for as long as benefit is shown. Patients will be evaluated periodically for 1 month.

这个子项目是众多研究子项目之一